(Q44668822)

5 December 2017

title

Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey (English)

1 reference

5 December 2017

0 references

1 reference

1 reference

5

1 reference

5 December 2017

Marjo-Riitta Järvelin

7

1 reference

5 December 2017

Saari K

1

1 reference

5 December 2017

Jokelainen J

2

1 reference

5 December 2017

Veijola J

3

1 reference

5 December 2017

Koponen H

4

1 reference

5 December 2017

Savolainen M

6

1 reference

5 December 2017

Lauren L

8

1 reference

5 December 2017

Isohanni M

9

1 reference

5 December 2017

Lindeman S

10

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

Acta Psychiatrica Scandinavica

5 December 2017

published in

1 reference

5 December 2017

volume

110

1 reference

5 December 2017

issue

4

1 reference

5 December 2017

page(s)

279-285

1 reference

Behavioural management of antipsychotic-induced weight gain: a review

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Weight gain: gained by waiting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Prevalence and correlates of diabetes in national schizophrenia samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Novel antipsychotics and severe hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Causes of the excess mortality of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Accuracy of hospital discharge data: five alcohol-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Early developmental milestones in adult schizophrenia and other psychoses. A 31-year follow-up of the Northern Finland 1966 Birth Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Prospective study of diet, lifestyle, and intermittent claudication in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2004.00358.X

10.1111/J.1600-0447.2004.00358.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference